Commissariat

AM Best Comments on Credit Ratings of LIA Holdings Limited and Its Rated Subsidiary Following a Fine From Commissariat aux Assurances

Retrieved on: 
Wednesday, March 27, 2024
Finance, Data Analytics, Professional Services, Other Professional Services, Insurance, EUR, Risk management, ALL, Commissariat, ALM, News, CAA, Credit, AM Best, Good, CTF

Concurrently, AM Best has commented that the Long-Term ICR of “bbb-” (Good) of LIA Holdings Limited (Lombard International) (United Kingdom), a non-operating holding company, remains unchanged.

Key Points: 
  • Concurrently, AM Best has commented that the Long-Term ICR of “bbb-” (Good) of LIA Holdings Limited (Lombard International) (United Kingdom), a non-operating holding company, remains unchanged.
  • Based on preliminary financial indicators, AM Best considers the fine to be immaterial to LIA's earnings and solvency level.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best’s Credit Ratings .
  • For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments .

Monument Re completes acquisition of Portfolio from Integrale Lux S.A.

Retrieved on: 
Friday, February 2, 2024
Professional Services, Insurance, Finance, Isle, Acquisition, Monument, Commissariat, Financial services

Monument Re announced today that its Luxembourg subsidiary Monument Assurance Luxembourg S.A. (“MAL”) completed the transfer of the closed book portfolio of long term life insurance business from Integrale Luxembourg S.A.

Key Points: 
  • Monument Re announced today that its Luxembourg subsidiary Monument Assurance Luxembourg S.A. (“MAL”) completed the transfer of the closed book portfolio of long term life insurance business from Integrale Luxembourg S.A.
  • The portfolio serves mainly the Luxembourgish, Dutch and French markets, and is strategically aligned to MAL’s existing business model.
  • The portfolio was transferred to MAL with unchanged terms and conditions for policyholders.
  • Monument Re Limited is a reinsurer and asset consolidator with a proven track record in the acquisition and operation of portfolios or direct insurers in Europe.

 Monument Re Acquires Portfolio From Integrale Lux S.A.

Retrieved on: 
Tuesday, May 16, 2023
Insurance, Professional Services, Bermuda Monetary Authority, Acquisition, Commissariat, Isle, Monument, Financial services

Monument Re announced today that its Luxembourg subsidiary Monument Assurance Luxembourg S.A. (“MAL”) reached an agreement with Integrale Luxembourg to acquire its closed book portfolio of long term life insurance business.

Key Points: 
  • Monument Re announced today that its Luxembourg subsidiary Monument Assurance Luxembourg S.A. (“MAL”) reached an agreement with Integrale Luxembourg to acquire its closed book portfolio of long term life insurance business.
  • The portfolio serves mainly the Luxembourgish, Dutch and French markets, and is strategically aligned to MAL’s existing business model.
  • Each entity is subject to local regulation and Monument Re is subject to Group Supervision by the Bermuda Monetary Authority.
  • Its strategy is to acquire, by portfolio transfer or outright purchase, legacy guaranteed and linked portfolios in Luxembourg, Italy and Spain.

AM Best Affirms Credit Ratings of CattRe S.A.

Retrieved on: 
Wednesday, February 1, 2023
Insurance, Professional Services, Credit, AM, Kapisanan ng mga Brodkaster ng Pilipinas, Generali, News, Cattolica, AM Best, EUR, Solvency II, Bernd, Commissariat, Solvency, ALL, Growth, Risk management, MGA

AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) of CattRe S.A. (CattRe) (Luxembourg).

Key Points: 
  • AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) of CattRe S.A. (CattRe) (Luxembourg).
  • The outlook of these Credit Ratings (ratings) is stable.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best’s Credit Ratings .
  • For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments .

Propelling quantum research across continents

Retrieved on: 
Wednesday, October 19, 2022
Photon, Institut national de la recherche scientifique, Universitate metro station, Communication, NSERC, INRS, Growth, Royal commission, Institute, Laval, Engineering, Research, Fraunhofer, University, Student, University of Vienna, Commissariat, Information technology, Internet, Fraunhofer Institute for Telecommunications, Interdisciplinarity, Faculty, Physics, Fraunhofer Society, Natural science, Atmosphere, Hyperspace, Solution, European Commission, Communications satellite, Microscope, Management, Renewable energy, Horizon Europe, QC, EU

The HyperSpace project is the result of this strategic collaboration and aims to develop a quantum communication network between continents.

Key Points: 
  • The HyperSpace project is the result of this strategic collaboration and aims to develop a quantum communication network between continents.
  • The overarching goal of HyperSpace is to further develop satellite-based quantum communications by appropriate experiments into scalable global quantum networks.
  • This global quantum network will interconnect a wide range of quantum processors using a variety of quantum channels, just as in the conventional Internet.
  • This project is part of a larger funding initiative of three research and innovation projects, from the EU and Canada, to support fundamental research in quantum technologies.

Monument Re Announces Merger of AME Life Lux S.A. Into Monument Assurance Luxembourg S.A.

Retrieved on: 
Monday, October 3, 2022
Insurance, Professional Services, Monument, Isle, Commissariat, Acquisition, Bermuda Monetary Authority, Solvency, Financial services

Monument Re announced today that AME Life Lux S.A. will merge into Monument Assurance Luxembourg S.A. following receipt of regulatory approval from the Commissariat aux Assurances.

Key Points: 
  • Monument Re announced today that AME Life Lux S.A. will merge into Monument Assurance Luxembourg S.A. following receipt of regulatory approval from the Commissariat aux Assurances.
  • As a result, Monument Assurance Luxembourg S.A. will be the sole Monument Luxembourg entity following the merger.
  • Monument Assurance Luxembourg S.A. is a fully licensed Luxembourg life insurance company regulated by the Commissariat aux Assurances, with branches in Spain, Italy, and Germany.
  • Its strategy is to acquire, by portfolio transfer or outright purchase, legacy guaranteed and linked portfolios in Luxembourg, Italy and Spain.

The QUID-NASH Research Consortium (Paris, France) and PharmaNest, Inc. (Princeton, USA) Enter a Strategic Partnership for the Study of NASH

Retrieved on: 
Wednesday, September 7, 2022
Beaujon Hospital, Partnership, Vascular disease, Paris Diderot University, CEO, National Institute, Imaging, SIB, Artificial intelligence, Liver, INSERM, Trial of the century, CEA, Seminal vesicles, Pathology, Artificiality, Digital pathology, Commissariat, Physics, Swiss Institute of Bioinformatics, Fatty liver disease, Diagnosis, Diabetes, Medical research, Inflammation, Type 2 diabetes, Fibrosis, GLOBE, Biostatistics, Leadership, Princeton University, NASH, University, Assistance, Data, Patient, QUID, Medical imaging, T2D, Beaujon

The clinical study involves 600 type 2 diabetic patients who are receiving a liver biopsy as part of standard care.

Key Points: 
  • The clinical study involves 600 type 2 diabetic patients who are receiving a liver biopsy as part of standard care.
  • This dataset will enrich the data collected and enable the consortium to discover novel histological phenotypes of NASH in T2D patients.
  • Its multivendor platform, FibroNest, is delivered worldwide via the cloud and used in multiple pre-clinical and clinical studies across several fibrotic conditions.
  • For more information about FibroNest and PharmaNest, visit www.pharmanest.com and www.fibronest.com

DGAP-News: Eckert & Ziegler Affiliate to Receive Multi-Million Euro Grant from the European Defense Fund for Development of Medical Countermeasures

Retrieved on: 
Thursday, August 4, 2022
Microsoft, Acute radiation syndrome, Infection, Radiation Sickness, Epidemic, Wastewater treatment, Subacute myelo-optic neuropathy, MCM, Nuclear medicine, National, Joint Chemical, Biological, Radiological and Nuclear Regiment, Industry, Program, Research, Commissariat, CEA, Radiation, National Institute, NATO, Medicine, ISIN, Therapy, Mortality, Toxicity, SDAX, CRBN, Deutsch, NIAID, ARS, Pharmaceutical industry, Medical imaging, EU, Chemical substance, Nuclear

The current program has the potential to advance its MCM candidate towards a marketing authorization application at the end of the four-year funding period.

Key Points: 
  • The current program has the potential to advance its MCM candidate towards a marketing authorization application at the end of the four-year funding period.
  • Beyond its potential as a medical countermeasure, the MCM portfolio has several promising clinical applications in mitigating radiation and chemotherapy-induced toxicity in nuclear medicine and (radiation) oncology.
  • About Eckert & Ziegler: Eckert & Ziegler Strahlen- und Medizintechnik AG with its 900 employees, is a leading global specialist for isotope-related applications in nuclear medicine, industry, and radiation therapy.
  • The primary manifestation of ARS is the depletion of hematopoietic stem and progenitor cells, constituting one of the major causes of mortality.

ILiAD Biotechnologies Receives NIH Grant to Develop Novel Tuberculosis Vaccine using proprietary B-Tech Vector Platform

Retrieved on: 
Tuesday, April 26, 2022
Biotechnology, General Health, Other Health, Health, Pharmaceutical, NIH, Lists of diseases, Bacteria, Vaccine, Memory B cell, Program, Infection, Review, Technology, Commissariat, BCG, Antigen, Radiobiology, Forward-looking statement, Investment, Ministry of Social Affairs, Ministry, Iliad, Medical research, Private Securities Litigation Reform Act, Moral and National Education controversy, Environment, Whooping cough, Fast track (FDA), Disease, Lists of publishing companies, National Institute of Allergy and Infectious Diseases, Tuberculosis, Medicine, Behavior, Twitter, WHO, TB, National, Bharath Institute of Higher Education and Research, Industry, Virus, Pasteur Institute, Cancer, Link, CEA, Genomics, Pasteur Institute of Lille, Person, NIAID, Parasitism, Bordetella pertussis, Innovation, National Institute, Diabetes, Degenerative disease, Pharmaceutical industry, Research, Biology, Health

ILiADs B-Tech Vector Platform utilizes a proprietary attenuated Bordetella pertussis (B. pertussis) strain as an intranasal vaccine vector to express pathogen target antigens, inducing both systemic and respiratory mucosal immunologic responses.

Key Points: 
  • ILiADs B-Tech Vector Platform utilizes a proprietary attenuated Bordetella pertussis (B. pertussis) strain as an intranasal vaccine vector to express pathogen target antigens, inducing both systemic and respiratory mucosal immunologic responses.
  • B-Tech Vector Platform vaccines have demonstrated immunogenicity in 8 peer-reviewed published pre-clinical studies targeting viruses, bacteria, and parasites.
  • In addition to preclinical development of B-Tech Vector vaccines for TB and other targets, ILiAD continues to advance its BPZE1 pertussis vaccine through late-stage clinical development.
  • ILiAD Biotechnologies is utilizing its B-Tech technology to develop next generation vaccines to prevent infectious diseases and improve lives.

Monument Re Acquires AME Life Lux S.A. From Covéa

Retrieved on: 
Monday, February 21, 2022
Insurance, Professional Services, Western Mutual Insurance Group, Bermuda Monetary Authority, Commissariat, Acquisition, Isle, Monument, Financial services

Monument Re announced today that its Luxembourg subsidiary, Monument Assurance Luxembourg S.A., has completed the acquisition of AME Life Lux S.A. (AMELL) from French Mutual Insurance Group, Cova, following receipt of regulatory approval from the Commissariat aux Assurances.

Key Points: 
  • Monument Re announced today that its Luxembourg subsidiary, Monument Assurance Luxembourg S.A., has completed the acquisition of AME Life Lux S.A. (AMELL) from French Mutual Insurance Group, Cova, following receipt of regulatory approval from the Commissariat aux Assurances.
  • AMELL is a well-established Luxembourg-based life insurance company with a market presence in Luxembourg and Belgium.
  • Through this strategy, Monument Re assumes asset-based risks within its risk appetite and efficiently operates these businesses or portfolios.
  • Monument Assurance Luxembourg S.A. is a fully licensed Luxembourg life insurance company regulated by the Commissariat aux Assurances, with branches in Spain, Italy, and Germany.